Delays in access to paediatric oncology care: Perspectives from eight partner hospitals
Article Sidebar
Main Article Content
Abstract
Background. Most newly diagnosed children with cancer live in low-and middle-income countries (LMIC) where challenges in access to diagnosis and treatment cause low survival rates.
Objective. To explore factors affecting delays in accessing paediatric oncology care at seven partner hospitals in LMIC (Malawi, Kenya, Tanzania and Kosovo) and one partner hospital in a high-income country (the Netherlands). Delays at community, primary/secondary and tertiary care levels are explored.
Methods. Leaders of paediatric oncology un its from all eight partner hospitals were interviewed using self-administered structured questionnaires in July and August 2023.
Results. Differences in diagnostics and treatment availability were observed between Dutch and LMIC settings. At the community level, all respondents acknowledged that parents’ inability to recognise cancer symptoms can lead to delays. Additional factors in LMICs included financial constraints, health beliefs and traditional medicine usage. At the primary/secondary care levels, all respondents acknowledged that misdiagnosis often delays referrals for children with suspected cancer. LMIC respondents also mentioned staff shortages and lack of health insurance. At the tertiary care level, only LMIC respondents reported delays, citing limited diagnostic or treatment modalities and a shortage of experienced staff. Across all settings, diagnosis delays were longer than treatment delays, with patient delays exceeding doctor delays, as noted by seven respondents. These factors contribute to low childhood cancer survival in LMICs.
Conclusion. Delays at all levels hinder prompt access to paediatric oncology care in LMICs. A multi-factorial approach is needed to assure timely access and improve survival.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. WHO Global Childhood Cancer Initiative. https://www.who.int/docs/default- source/documents/health-topics/cancer/who-childhood-cancer-overview- booklet.pdf (accessed 24 October 2022).
2. Levesque JF, Harris MF, Russell G. Patient-centred access to health care: Conceptualising access at the interface of health systems and populations. Int J Equity Health 2013;12(1):1-9. https://doi.org/10.1186/1475-9276-12-18
3. Cotache-Condor C, Kantety V, Grimm A, et al. Determinants of delayed childhood cancer care in low- and middle-income countries: A systematic review. Pediatr Blood Cancer 2023;70(3):e30175. https://doi.org/10.1002/pbc.30175
4. Njuguna F, Martijn H, Langat S, et al. Factors influencing time to diagnosis and treatment among pediatric oncology patients in Kenya. Pediatr Hematol Oncol 2016;33(3):186-199. https://doi.org/10.3109/08880018.2016.1169566
5. Ngwa W, Addai BW, Adewole I, et al. Cancer in sub-Saharan Africa: A Lancet Oncology Commission. Lancet Oncol 2022;23(6):e251-312. https://doi. org/10.1016/S1470-2045(21)00720-8
6. Kuhlthau KA, Nipp RD, Shui A, et al. Health insurance coverage, care accessibility and affordability for adult survivors of childhood cancer: A cross-sectional study of a nationally representative database. J Cancer Surviv 2016;10(6):964-971. https:// doi.org/10.1007/s11764-016-0542-7
7. Yaya S, Sanogo AN. Universal health coverage and facilitation of equitable access to care in Africa: A systematic review. Front Pub Health 2019;7:102. https://doi.org/10.3389/fpubh.2019.00102
8. Olbara G, Martijn HA, Njuguna F, et al. Influence of health insurance status on childhood cancer treatment outcomes in Kenya. Support Care Cancer 2020;28(2):917-924. https://doi.org/10.1007/s00520-019-04859-1
9. Kanwar VS, Schwartz KR, Salifu N, et al. The role of twinning in sustainable care for children with cancer: A TIPPing point? SIOP PODC Working Group on Twinning, Collaboration, and Support. Pediatr Blood Cancer 2020;67(11):e28667. https://doi.org/10.1002/pbc.28667
10. World Bank country classification 2022. https://datatopics.worldbank.org/ world-development-indicators/the-world-by-income-and-region.html (accessed 23 October 2023).
11. Dang-Tan T, Franco EL. Diagnosis delays in childhood cancer: A review. Cancer 2007;110(4):703-713. https://doi.org/10.1002/cncr.22849
12. Handayani K, Sitaresmi MN, Supriyadi E, et al. Delays in diagnosis and treatment of childhood cancer in Indonesia. Pediatr Blood Cancer 2016;63(12):2189-2196. https://doi.org/10.1002/pbc.26174
13. Geel JA, Challinor J, Ranasinghe N, et al. Pediatric cancer care in Africa: SIOP Global Mapping Program report on economic and population indicators. Pediatr Blood Cancer 2021;68(11):e29345. https://doi.org/10.1002/pbc.29345
14. Diorio C, Lam CG, Ladas EJ, et al. Global use of traditional and complementary medicine in childhood cancer: A systematic review. J Glob Oncol 2017;3(6):791- 800. https://doi.org/10.1200/JGO.2016.005587
15. Afungchwi GM, Kruger M, Hesseling P, van Elsland S, Ladas EJ, Marjerrison S. Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon. Pediatr Blood Cancer 2022;69(8):e29675. https://doi.org/10.1002/pbc.29675
16. Tumlinson K, Gichane MW, Curtis SL, LeMasters K. Understanding healthcare provider absenteeism in Kenya: A qualitative analysis. BMC Health Serv Res 2019;19(1):660. https://doi.org/10.1186/s12913-019-4435-0
17. Fajardo-Gutiérrez A, Sandoval-Mex AM, Mejía-Aranguré JM, Rendón- Macías ME, M del C Martínez-García. Clinical and social factors that affect the time to diagnosis of Mexican children with cancer. Int Soc Pediatr Oncol 2002;39(1):25-31. https://doi.org/10.1002/mpo.1010018. Dang-Tan T, Trottier H, Mery LS, et al. Delays in diagnosis and treatment among children and adolescents with cancer in Canada. Pediatr Blood Cancer 2008;51(4):468-474. https://doi.org/10.1002/pbc.21600
19. Zabih W, Thota AB, Mbah G, Freccero P, Gupta S, Denburg AE. Interventions to Med Pediatr Oncol. Improve early detection of childhood cancer in low- and middle-income countries: A systematic review. Pediatr Blood Cancer 2020;67(12):e28761. https://doi.org/10.1002/pbc.28761
20. Brand NR, Qu LG, Chao A, Ilbawi AM. Delays and barriers to cancer care in low- and middle-income countries: A systematic review. Oncologist 2019;24(12):e1371-e1380. https://doi.org/10.1634/theoncologist.2019-0057
21. Dobrovoljac M, Hengartner H, Boltshauser E, Grotzer MA. Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr 2002;161(12):663-667. https://doi.org/10.1007/s00431-002-1088-4
22. Njuguna F, Mostert S, Seijffert A, et al. Parental experiences of childhood cancer treatment in Kenya. Supportive Care Cancer 2015;23:1251-1259. https://doi. org/10.1007/s00520-014-2475-x